Advertisement
U.S. markets closed

Treace Medical Concepts, Inc. (TMCI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
13.05+0.69 (+5.58%)
At close: 04:00PM EDT
13.05 +0.00 (+0.01%)
After hours: 04:04PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close12.36
Open12.41
Bid12.99 x 300
Ask13.10 x 400
Day's Range12.41 - 13.20
52 Week Range5.27 - 27.97
Volume333,121
Avg. Volume524,063
Market Cap805.904M
Beta (5Y Monthly)0.28
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for TMCI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Treace Medical Concepts, Inc.
    Daily – Vickers Top Buyers & Sellers for 06/12/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    10 months agoArgus Research
View more
  • GlobeNewswire

    Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone

    Treace 100K+ Lapiplasty® Patients Treace Medical Celebrates 100K+ Lapiplasty® Patients Lauren - Lapiplasty® Patient and Collegiate Diver Lauren, Lapiplasty® Patient and Collegiate Diver Lauren - Lapiplasty® Patient Lapiplasty® Patient Lauren Working Out Treace Lapiplasty® Procedure Lapiplasty® - The Future of Bunion Surgery is Here Treace Further Expands Focus on Bunion Deformity Education by Sponsoring First-Ever National Bunion Day in the U.S. on April 16, 2024 Launches New “Future You” Patien

  • GlobeNewswire

    Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance

    PONTE VEDRA, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today reported financial results for the fourth quarter and full year ended December 31, 2023 and provided 2024 guidance. Recent Highlights Revenue of $62.2 million in fourth quarte

  • GlobeNewswire

    Treace to Report Fourth Quarter and Full-Year 2023 Financial Results

    Company to Host Conference Call on Tuesday, February 27, 2024 at 4:30 pm ETPONTE VEDRA, Fla., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced that it will release financial results for the fourth quarter and full year of 2023 after